Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02641145 · ClinicalTrials.gov registry record · NA
Molecular Imaging of Primary Amyloid Cardiomyopathy
A NA study of Cardiomyopathy and Amyloidosis, Primary, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 171
- Enrollment target
- 1
- Study location
NCT02641145 is a NA study of Cardiomyopathy and Amyloidosis, Primary that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 171 participants, below the 550-participant average among 25 other Cardiomyopathy trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02641145, a NA study of Cardiomyopathy and Amyloidosis, Primary, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 171 participants
- Enrollment target
- 1
- Study location
Study Summary
Cardiac amyloidosis is a major cause of early treatment-related death and poor overall survival in individuals with systemic light chain amyloidosis. This project will develop a novel approach to visualize cardiac amyloid deposits using advanced imaging methods. The long-term goal of this work is to identify the mechanisms of cardiac dysfunction, in order to guide the development of novel life-saving treatments.
Conditions Studied
Interventions
- RADIATION F-18 florbetapir/C-11 acetate PET
- DEVICE MRI
- RADIATION N-13 ammonia PET
Study Locations (1)
Massachusetts
- Brigham and Womens' Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2016-04-01 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02641145
The ClinicalTrials.gov registry entry for NCT02641145 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 550-participant average among 25 other Cardiomyopathy trials with a reported enrollment target (69% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cardiomyopathy appearing as the primary indexed condition, and to 3 interventions - of which F-18 florbetapir/C-11 acetate PET is the first listed.
NCT02641145 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02641145 about?
NCT02641145 is a clinical study titled "Molecular Imaging of Primary Amyloid Cardiomyopathy". Cardiac amyloidosis is a major cause of early treatment-related death and poor overall survival in individuals with systemic light chain amyloidosis. This project will develop a novel approach to visualize cardiac amyloid deposits using advanced imaging methods. The long-term goal of this work is to...
What is the current status of trial NCT02641145?
This trial is currently recruiting. It is a NA study. The enrollment target is 171 participants. The study started on 2016-04-01. Estimated completion is 2028-12-31.
What conditions does trial NCT02641145 study?
This clinical trial studies the following conditions: Cardiomyopathy, Amyloidosis, Primary.
What interventions are being tested in trial NCT02641145?
The interventions under investigation include: F-18 florbetapir/C-11 acetate PET (RADIATION), MRI (DEVICE), N-13 ammonia PET (RADIATION).
Who is sponsoring clinical trial NCT02641145?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02641145 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiomyopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Large Language Models To Improve the Quality of Care of Cardiology Patients
RECRUITING · NA
-
Evaluating Myocardial Injury for Defibrillation Threshold Testing Methods for ICD Implantation
COMPLETED · NA
-
Telephone Intervention in Heart Failure Patients
COMPLETED · NA
-
Resistance and Aerobic Exercise for Subclinical Anthracycline Cardiomyopathy
COMPLETED · NA
-
RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators
COMPLETED · NA
-
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.